Collaborations Sample Clauses

Collaborations a. With other CDC programs and CDC-funded organizations: b. With organizations not funded by CDC:

Collaborations. Contractor shall form partnerships and collaborations Insert collaborations required.

Collaborations. If granting the technology access to a ▇▇▇▇▇ ▇▇▇▇▇▇ Entity does not fall into Section 2.01(a)(ii)(A) above, then such access shall not be included as a CA Service provided in consideration for the Corporate Assessment and the relevant GE Entity and ▇▇▇▇▇ ▇▇▇▇▇▇ Entity shall use good faith efforts to reach agreement upon the terms of a Collaboration Agreement in accordance with Section 3.13, including, if necessary, proposing modifications to the proposed request in order to reach such agreement.

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript must be submitted for review by ▇▇▇▇. 7.1.a If the manuscript is approved by ▇▇▇▇, the Recipient and Recipient’s PI agree to include the acknowledgment found on the ▇▇▇▇ Study website at ▇▇▇▇▇://▇▇▇▇▇.▇▇▇▇.▇▇▇.▇▇▇/▇▇▇▇/pubs-policies-and-forms-pg and the following statement. “This manuscript has been reviewed by the ▇▇▇▇ study for scientific content and consistency of data interpretation with previous ▇▇▇▇ publications.” 7.1.b If the manuscript is not approved by ▇▇▇▇ and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the acknowledgment found on the ▇▇▇▇ Study website at ▇▇▇▇▇://▇▇▇▇▇.▇▇▇▇.▇▇▇.▇▇▇/▇▇▇▇/pubs-policies-and-forms-pg and the following statement. “This manuscript was not approved by the ▇▇▇▇ Study. The opinions and conclusions contained in this publication are solely those of the authors, and are not endorsed by the ▇▇▇▇ Study or the NHLBI and should not be assumed to reflect the opinions or conclusions of either.”

Collaborations. (a) A GE Entity, on the one hand, and a ▇▇▇▇▇ ▇▇▇▇▇▇ Entity, on the other, may agree from time to time to enter into a Collaboration pursuant to the terms of a Collaboration Agreement in a form substantially similar to the Collaboration Agreement set forth on Schedule 3 .13(a); provided that any research and technology collaboration with GE’s Digital division shall be governed by the terms of the GE Digital Master Products and Services Agreement. Collaboration Agreements should contain the following elements: (i) projected total and annual funding levels for the collaboration, including the funding level for any ▇▇▇▇▇ ▇▇▇▇▇▇ Entity, GE Entity and/or any Governmental Authority and any specified funding limitations; (ii) provisions regarding ownership of Intellectual Property developed in connection with the collaboration; (iii) if applicable, provisions regarding restrictions on the use of any Intellectual Property relevant to such Collaboration Agreement which shall limit the licenses granted in this Section 3.13; (iv) if applicable, provisions regarding additional protections for Highly Confidential Information; (v) the term of such Collaboration Agreement, including any renewal options, termination rights and related notice periods; and (vi) such other provisions as are applicable to a specific Collaboration Agreement (which may include representations, warranties and indemnification provisions; provided that in such case, the Provider shall be entitled to adjust the price of such applicable Collaboration Services to reflect any such risk allocation included in the Collaboration Agreement. (b) ▇▇▇▇▇ ▇▇▇▇▇▇ hereby grants and agrees to grant, and cause its Affiliates to grant and agree to grant, to the GE Entities a royalty-free, fully paid-up, non-exclusive, limited right and license, with no right to sublicense, to any of its or their Background IP that is Controlled by the ▇▇▇▇▇ ▇▇▇▇▇▇ or its Affiliates, solely as applicable, to perform the obligations of the GE Entities under the applicable Collaboration Agreement. (c) GE hereby grants and agrees to grant, and cause its Affiliates to grant and agree to grant, to the ▇▇▇▇▇ ▇▇▇▇▇▇ Entities a royalty-free, fully paid-up, non-exclusive, limited right and license, with no right to sublicense, to any of its or their Background IP that is Controlled by the GE or its Affiliates, solely as applicable, to perform the obligations of the ▇▇▇▇▇ ▇▇▇▇▇▇ Entities under the applicable Collaboration Agreement. (d) The P...

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript will be reviewed by the JHS. 7.1.a If the manuscript is approved by the JHS, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. 7.1.b If the manuscript is not approved by the JHS and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment.

Collaborations. If a manuscript resulting from the Research Project has Study Investigators as co-authors, then the manuscript will be reviewed by SPIROMICS and SOURCE. 7.1.a If the manuscript is approved by SPIROMICS and/or SOURCE, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622).” “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718).” 7.1.b If the manuscript is not approved by the SPIROMICS and/or SOURCE studies and the Recipient and Recipient’s PI wish to proceed to publish without inclusion of Study Investigators as co-authors, the Recipient and Recipient’s PI agree to include the following language in an acknowledgment. “The Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN268200900019C, HHSN268200900020C, U01 HL137880, U24 HL141762, and R01 HL182622). “SPIROMICS Study of Early COPD Progression (SOURCE) is funded by the National Heart, Lung, and Blood Institute (NHLBI) (R01 HL144718).” “The opinions and conclusions contained in this publication are solely those of the authors, and are not endorsed by SPIROMICS, SOURCE, or the NHLBI and should not be assumed to reflect the opinions or conclusions of either.”

Collaborations. If granting the technology access to a GE Entity does not fall into Section 2.02(a)(A) above, then the relevant GE Entity and ▇▇▇▇▇ ▇▇▇▇▇▇ Entity shall use good faith efforts to reach agreement upon the terms of a Collaboration Agreement in accordance with Section 3.13, including, if necessary, proposing modifications to the proposed request in order to reach such agreement.

Collaborations. If a manuscript resulting from the Research Project has SPIROMICS and/or SOURCE Investigators as co-authors, then the manuscript will be reviewed by SPIROMICS and SOURCE Publications and Presentations Committee in accordance with Section 5 (Publication). 7.1.a. If the manuscript is reviewed and approved by SPIROMICS and/or SOURCE, the Recipient agrees to include the following language in an acknowledgment. 7.1.b. If the manuscript is not reviewed by SPIROMICS and/or SOURCE and the